Cargando…
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors
Advancement in sequencing technologies allows for the identification of molecular pathways involved in tumor progression and treatment resistance. Implementation of novel agents targeting these pathways, defined as targeted therapy, significantly improves the prognosis of cancer patients. Targeted t...
Autores principales: | Liguori, Luigi, Polcaro, Giovanna, Nigro, Annunziata, Conti, Valeria, Sellitto, Carmine, Perri, Francesco, Ottaiano, Alessandro, Cascella, Marco, Zeppa, Pio, Caputo, Alessandro, Pepe, Stefano, Sabbatino, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694302/ https://www.ncbi.nlm.nih.gov/pubmed/36432631 http://dx.doi.org/10.3390/pharmaceutics14112442 |
Ejemplares similares
-
Prior Anti-Angiogenic TKI-Based Treatment as Potential Predisposing Factor to Nivolumab-Mediated Recurrent Thyroid Disorder Adverse Events in mRCC Patients: A Case Series
por: Liguori, Luigi, et al.
Publicado: (2023) -
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma
por: Sabbatino, Francesco, et al.
Publicado: (2020) -
Molecules and Mechanisms to Overcome Oxidative Stress Inducing Cardiovascular Disease in Cancer Patients
por: Sabbatino, Francesco, et al.
Publicado: (2021) -
Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study
por: Ottaiano, Alessandro, et al.
Publicado: (2023) -
PD-L1 Dysregulation in COVID-19 Patients
por: Sabbatino, Francesco, et al.
Publicado: (2021)